Is There A Better Place To Decide What’s Right For Patients?
Who should decide when evidence for a drug sufficient to support a patient’s decision to give it a try?
writer, health care advocate, physician
Who should decide when evidence for a drug sufficient to support a patient’s decision to give it a try?
Can you perform a sentinel lymph node biopsy, and avoid removing all of the glands from my armpit?
Prior to the program’s start, maternal mortality for women with sickle cell disease exceeded 9% at the teaching hospital. With team-based care, the death rate fell to 1%.
DCIS accounts for approximately 1 in 5 breast cancer-ish diagnoses in the United States. The practical problem with DCIS is that most oncologists, surgical and medical, will admit they’re not sure what to do about it.
If overtreatment is the problem, the solution is not by avoidance of breast cancer detection, but by better education of physicians and patients.
Researchers today are analyzing our grandmothers’ mammograms to inform women’s health and screening decisions today.
To issue sound guidelines on breast cancer screening, would the USPSTF benefit by including an oncologist or radiologist on the panel?
“There is no ‘race for the palliation,’” said Dr. Michael Levy, MD, PhD of Fox-Chase Cancer Center, a palliative care specialist.
Gastroenterologists vary widely in their “pick-up” rates. Although it’s widely accepted that colon cancer screening by colonoscopy can be life-saving, it’s unknown to what extent the doctors’ skills make a difference.
Few forms of invasive breast cancer warrant no treatment unless the patient is so old that she is likely to die first of another condition, or the patient prefers to die of the disease….“Mammograms Spot Cancers That May Not Be Dangerous,” said….
An article in the March 24 NEJM called Specialization, Subspecialization, and Subsubspecialization in Internal Medicine might have some heads shaking: Isn’t there a shortage of primary care physicians?